This guidance is for healthcare professionals who care for women ... It is also under investigation for other autoimmune conditions such as myasthenia gravis. In the UNITY trial, 13 women at high risk ...

A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the ...

This CME program is designed to enhance neurologists' understanding and management of generalized myasthenia gravis (gMG). Participants will explore how comprehensive assessment of disease burden ...

A sustained-release form of pyridostigmine bromide (Mestinon Timespan) has been in use since 1956. This is a scored, slowly-absorbable tablet containing 180 mg. of pyridostigmine bromide or the ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

BI-covered insurance brokers may have room for upside to average consensus organic sales growth ... consulting and claims management. Such businesses diversify earnings, and though some are ...

The OfS aims to help students succeed in Higher Education by ensuring they receive excellent information and guidance, get high quality education that prepares them for the future and by protecting ...

New tremors rattled survivors of Friday’s earthquake, which killed more than 1,600 people, while the government continued its bombing campaign elsewhere in the country. By Sui-Lee Wee ...

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company ...

Efgartigimod is a newly approved FcRn antagonist for the treatment of myasthenia gravis, which rapidly cleans IgG antibodies in the body, but there is still a lack of guidance on the use of ...